Goldman Sachs and Primavera, an investment firm, led the $108m investment round in Shukun, an AI-powered medical diagnosis firm. Other investors include Sequoia Capital China, Marathon Venture Partners, Jane Street, WT Asset Management and Sage Partners. The fresh funding would be used to invest in R&D of its AI product. Additionally, cash will help increase the pace of commercialization of the company's products.